Article
Disease severity in K/BxN serum transfer-induced arthritis is not affected by IL-33 deficiency.
Arthritis research & therapy - 16 Jan 2013
Martin Praxedis, Talabot-Ayer Dominique, Seemayer Christian Alexander, Vigne Solenne, Lamacchia Céline, Rodriguez Emiliana, Finckh Axel, Smith Dirk E, Gabay Cem, Palmer Gaby
Abstract excerpt
INTRODUCTION: Interleukin (IL)-33 is a cytokine of the IL-1 family, which signals through the ST2 receptor. Previous work suggested implication of the IL-33/ST2 axis in the pathogenesis of human and mouse arthritis. Here, we directly investigated the role of endogenous IL-33 in K/BxN serum transfer-induced arthritis by using IL-33 knockout (KO) mice. METHODS: Arthritis was induced by injection of complete K/BxN...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
